DataMeds AI (MEDS) Net Cash Flow (2024 - 2026)

DataMeds AI (MEDS) has reported Net Cash Flow for 3 consecutive years, with $9159.0 the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow fell 99.38% year-over-year to $9159.0; the trailing twelve-month figure through Mar 2026 stood at -$2.5 million (down 209.96% YoY), and the FY2025 full-year result was -$985765.0, down 195.99% from the prior year.
• Net Cash Flow climbed to $9159.0 in Q1 2026 per MEDS's latest filing, from -$4.2 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $3.8 million in Q3 2025 and bottomed at -$4.2 million in Q4 2025.
• Historically, Net Cash Flow has averaged $7545.7 across 3 years, with a median of $235188.0 in 2024.
• The widest YoY moves for Net Cash Flow: up 424.49% in 2025, down 1879.89% in 2025.
• Over 3 years, Net Cash Flow stood at $235188.0 in 2024, then plunged by 1879.89% to -$4.2 million in 2025, then jumped by 100.22% to $9159.0 in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered $9159.0, -$4.2 million, and $3.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.